MedPath

PREdiction and PREvention of Diabetes using Metformin or Lifestyle Intervention with Economic Evaluation Research

Phase 1
Conditions
Prediabetes
Prediabetes, diabetes, impaired fasting glucose, impaired glucose tolerance, gut microbiota
Registration Number
TCTR20211116001
Lead Sponsor
ational Research Council of Thailand
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending (Not yet recruiting)
Sex
All
Target Recruitment
520
Inclusion Criteria

prediabetic patients who has either FPG 100-125 mg/dL, 2 h OGTT 140-199 mg/dL, or HbA1C 5.7-6.4%

Exclusion Criteria

Diabetic patients
Pregnancy
HIV infection
patients with ASCVD
LBBB
CHF NY class > II
CKD
hepatitis
weight loss > 10% in 6 months

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
conversion to diabetes 3 years rate of conversion to diabetes
Secondary Outcome Measures
NameTimeMethod
factors that associated with conversion to diabetes 3 years association
© Copyright 2025. All Rights Reserved by MedPath